Michael W. Freeman
Stock Analyst at Raymond James
(2.06)
# 3,093
Out of 4,429 analysts
43
Total ratings
37.9%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Michael W. Freeman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: AIDX Healwell AI Inc. | Maintained: Buy | $3.00 → $2.50 | $0.80 | +212.50% | 5 | Mar 25, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Maintained: Buy | $6.00 → $7.00 | $4.34 | +61.29% | 2 | Nov 18, 2025 | |
| TSX: WELL WELL Health Technologies Corp. | Maintained: Buy | n/a | $4.17 | - | 5 | Nov 6, 2025 | |
| TSX: PRN Profound Medical Corp. | Maintained: Buy | $15.57 | $9.60 | +62.16% | 4 | Oct 8, 2025 | |
| TSX: MDP Medexus Pharmaceuticals Inc. | Maintained: Buy | $8.00 | $4.20 | +90.48% | 9 | Aug 14, 2025 | |
| TSX: VHI Vitalhub Corp. | Maintained: Buy | $14.50 → $15.00 | $7.05 | +112.77% | 6 | Aug 12, 2025 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $11.32 | $6.57 | +72.33% | 7 | Aug 5, 2025 | |
| NGEN NervGen Pharma | Maintained: Buy | $3.18 → $4.24 | $2.20 | n/a | 3 | Jun 11, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.00 | $9.27 | n/a | 1 | Mar 12, 2025 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Upgraded: Buy | $1.50 | $0.295 | n/a | 1 | Nov 18, 2024 |
Healwell AI Inc.
Mar 25, 2026
Maintained: Buy
Price Target: $3.00 → $2.50
Current: $0.80
Upside: +212.50%
HLS Therapeutics Inc.
Nov 18, 2025
Maintained: Buy
Price Target: $6.00 → $7.00
Current: $4.34
Upside: +61.29%
WELL Health Technologies Corp.
Nov 6, 2025
Maintained: Buy
Price Target: n/a
Current: $4.17
Upside: -
Profound Medical Corp.
Oct 8, 2025
Maintained: Buy
Price Target: $15.57
Current: $9.60
Upside: +62.16%
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Maintained: Buy
Price Target: $8.00
Current: $4.20
Upside: +90.48%
Vitalhub Corp.
Aug 12, 2025
Maintained: Buy
Price Target: $14.50 → $15.00
Current: $7.05
Upside: +112.77%
Bausch Health Companies Inc.
Aug 5, 2025
Maintained: Hold
Price Target: $11.32
Current: $6.57
Upside: +72.33%
NervGen Pharma
Jun 11, 2025
Maintained: Buy
Price Target: $3.18 → $4.24
Current: $2.20
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Maintained: Buy
Price Target: $8.00
Current: $9.27
Upside: n/a
Perimeter Medical Imaging AI, Inc.
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.295
Upside: n/a